Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Trichoscopy is a helpful and quick method to diagnose hair loss without shaving.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

The anti-ageing treatment market is growing by exploiting fears of ageing with unproven promises, which could harm public trust and genuine science.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Apremilast shows promise for several skin conditions but needs more research.

Exosomes may help with hair growth and scar healing, but more research is needed.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Finasteride shows promise for female hair loss, but more research needed.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

The document doesn't provide enough information to summarize.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.